In fact, the presence of the high frequency of tirap S180L variant in Iranian malaria patients with mild malaria might support the role of this SNP in protection against severe malaria by intermediate levels of pathway activation and balanced inflammatory response (by attenuates TLR-2 and TLR-4 signaling pathways). This evidence concerns the gene TLR2 and malaria.